Metastatic lung adenocarcinoma causing sudden hearing loss and vertigo
This lung cancer diagnosis at a glance
- Stage at diagnosis
- Stage IV
- Subtype
- Adenocarcinoma
- Sex
- Female
- Spread to
- bone|liver|brain|internal auditory meatus
- Treatment
- immunotherapy and radiation
- Outcome
- Setback / Progression
Treatment course, step by step
- Treated with nivolumab immunotherapy for metastatic lung adenocarcinoma.
- Received palliative radiotherapy.
What happened, in summary
A 69-year-old woman developed 2 weeks of left-sided hearing loss and progressively worsening vertigo. Ten months earlier, she had been diagnosed with lung adenocarcinoma that had spread to the bones, liver and brain, making this Stage IV disease. Her cancer had been managed with nivolumab immunotherapy, steroids and palliative radiotherapy.
During the new episode, examination showed right-beating nystagmus and mild left facial nerve weakness. Hearing testing confirmed new deafness in the left ear compared with a test performed 8 months earlier. The combination of rapidly progressive hearing loss, vertigo and facial weakness was linked to metastatic involvement of the internal auditory meatus, an uncommon site close to the hearing and facial nerves.
The new metastatic involvement represented another setback in an already widespread lung-cancer course. At this point, she had progressive metastatic disease involving multiple distant sites together with new neurologic and ear-related symptoms.
Where this story comes from
This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full
How we source and attribute stories Accuracy and limitations
Collections this story belongs to
- Stage 4 Lung Cancer 384 stories
- Immunotherapy for Stage 4 Lung Cancer 146 stories
- Immunotherapy for Lung Cancer 237 stories
These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer